KalVista Pharmaceuticals
KALV
#6541
Rank
C$0.75 B
Marketcap
$15.23
Share price
-5.39%
Change (1 day)
0.29%
Change (1 year)

Earnings for KalVista Pharmaceuticals (KALV)

Earnings in 2025 (TTM): -C$0.24 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.25 Billion a decrease over its 2023 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KalVista Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.24 Billion-1.69%
2024 -C$0.25 Billion43.36%
2023 -C$0.18 Billion12.87%
2022 -C$0.16 Billion20.62%
2021 -C$0.13 Billion79.87%
2020 -C$69.44 Million14.01%
2019 -C$60.91 Million98.95%
2018 -C$30.62 Million3.41%
2017 -C$29.61 Million-13.11%
2016 -C$34.08 Million1.3%
2015 -C$33.64 Million92.7%
2014 -C$17.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.21 Billion-16.65%๐Ÿ‡บ๐Ÿ‡ธ USA